Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1947 1
1949 1
1952 1
1954 1
1956 1
1957 1
1961 1
1963 1
1968 2
1973 2
1974 4
1975 3
1976 3
1977 2
1978 5
1979 1
1980 4
1981 1
1982 3
1983 1
1985 2
1986 1
1987 3
1988 1
1989 1
1991 3
1992 3
1993 2
1994 2
1995 4
1996 1
1997 2
1999 2
2002 2
2003 3
2004 3
2005 3
2006 2
2007 1
2008 1
2009 3
2010 5
2011 3
2012 7
2013 5
2014 6
2015 4
2016 6
2017 3
2018 4
2019 1
2020 9
2021 3
2022 5
2023 4
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
McGarry A, Rosanbalm S, Leinonen M, Olanow CW, To D, Bell A, Lee D, Chang J, Dubow J, Dhall R, Burdick D, Parashos S, Feuerstein J, Quinn J, Pahwa R, Afshari M, Ramirez-Zamora A, Chou K, Tarakad A, Luca C, Klos K, Bordelon Y, St Hiliare MH, Shprecher D, Lee S, Dawson TM, Roschke V, Kieburtz K. McGarry A, et al. Among authors: burdick d. Lancet Neurol. 2024 Jan;23(1):37-45. doi: 10.1016/S1474-4422(23)00378-2. Lancet Neurol. 2024. PMID: 38101901 Clinical Trial.
Causal Rasch models.
Stenner AJ, Fisher WP Jr, Stone MH, Burdick DS. Stenner AJ, et al. Among authors: burdick ds. Front Psychol. 2013 Aug 23;4:536. doi: 10.3389/fpsyg.2013.00536. eCollection 2013. Front Psychol. 2013. PMID: 23986726 Free PMC article.
CORD-19: The Covid-19 Open Research Dataset.
Wang LL, Lo K, Chandrasekhar Y, Reas R, Yang J, Burdick D, Eide D, Funk K, Katsis Y, Kinney R, Li Y, Liu Z, Merrill W, Mooney P, Murdick D, Rishi D, Sheehan J, Shen Z, Stilson B, Wade AD, Wang K, Wang NXR, Wilhelm C, Xie B, Raymond D, Weld DS, Etzioni O, Kohlmeier S. Wang LL, et al. Among authors: burdick d. ArXiv [Preprint]. 2020 Apr 22:arXiv:2004.10706v4. ArXiv. 2020. PMID: 32510522 Free PMC article. Preprint.
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease.
Olanow CW, Hauser RA, Burdick DJ, Dhall R, de Marcaida JA, Gil RA, Kreitzman DL, Elmer LW, McGarry A, Kieburtz K; P2B Study Group. Olanow CW, et al. Among authors: burdick dj. Mov Disord. 2024 Feb;39(2):350-359. doi: 10.1002/mds.29642. Epub 2023 Oct 27. Mov Disord. 2024. PMID: 37886872 Clinical Trial.
A Multifaceted Hit-Finding Approach Reveals Novel LC3 Family Ligands.
Steffek M, Helgason E, Popovych N, Rougé L, Bruning JM, Li KS, Burdick DJ, Cai J, Crawford T, Xue J, Decurtins W, Fang C, Grubers F, Holliday MJ, Langley A, Petersen A, Satz AL, Song A, Stoffler D, Strebel Q, Tom JYK, Skelton N, Staben ST, Wichert M, Mulvihill MM, Dueber EC. Steffek M, et al. Among authors: burdick dj. Biochemistry. 2023 Feb 7;62(3):633-644. doi: 10.1021/acs.biochem.1c00682. Epub 2022 Jan 5. Biochemistry. 2023. PMID: 34985287 Free article.
Design of Organo-Peptides As Bipartite PCSK9 Antagonists.
Burdick DJ, Skelton NJ, Ultsch M, Beresini MH, Eigenbrot C, Li W, Zhang Y, Nguyen H, Kong-Beltran M, Quinn JG, Kirchhofer D. Burdick DJ, et al. ACS Chem Biol. 2020 Feb 21;15(2):425-436. doi: 10.1021/acschembio.9b00899. Epub 2020 Jan 30. ACS Chem Biol. 2020. PMID: 31962046
Identification of a PCSK9-LDLR disruptor peptide with in vivo function.
Brousseau ME, Clairmont KB, Spraggon G, Flyer AN, Golosov AA, Grosche P, Amin J, Andre J, Burdick D, Caplan S, Chen G, Chopra R, Ames L, Dubiel D, Fan L, Gattlen R, Kelly-Sullivan D, Koch AW, Lewis I, Li J, Liu E, Lubicka D, Marzinzik A, Nakajima K, Nettleton D, Ottl J, Pan M, Patel T, Perry L, Pickett S, Poirier J, Reid PC, Pelle X, Seepersaud M, Subramanian V, Vera V, Xu M, Yang L, Yang Q, Yu J, Zhu G, Monovich LG. Brousseau ME, et al. Among authors: burdick d. Cell Chem Biol. 2022 Feb 17;29(2):249-258.e5. doi: 10.1016/j.chembiol.2021.08.012. Epub 2021 Sep 20. Cell Chem Biol. 2022. PMID: 34547225 Free article.
Barcoding and mitochondrial phylogenetics of Porites corals.
Combosch DJ, Burdick D, Primov K, Rios D, Rios K, Fernandez J. Combosch DJ, et al. Among authors: burdick d. PLoS One. 2024 Feb 15;19(2):e0290505. doi: 10.1371/journal.pone.0290505. eCollection 2024. PLoS One. 2024. PMID: 38359055 Free PMC article.
Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors.
Burdick DJ, Wang S, Heise C, Pan B, Drummond J, Yin J, Goeser L, Magnuson S, Blaney J, Moffat J, Wang W, Chen H. Burdick DJ, et al. Bioorg Med Chem Lett. 2015 Nov 1;25(21):4728-4732. doi: 10.1016/j.bmcl.2015.08.048. Epub 2015 Aug 22. Bioorg Med Chem Lett. 2015. PMID: 26338362
149 results